| Predicate | Object |
|---|---|
| rdf:type | |
| biopax3:comment |
FGFR2 is inhibited by a range of in vitro tyrosine kinase inhibitors, including PD170734 and SU5402 (reviewed in Greulich and Pollock, 2010; Wesche, 2011). In addition, there are a number of FGFR2 inhibitors currently in clinical trials that for treatment of solid malignancies (http://ClinicalTrials.gov).
|
| biopax3:xref | |
| biopax3:evidenceCode |